Indian Council for Medical Research has revised its advisory on the use of HCQ. Hydroxychloroquine should only be given on the advice of the registered medical practitioner.
A meeting of Joint Monitoring Group was helda, after which advisory was issued. Thia meeting was attended by ICMR, National Center for Disease Control, World Health Organization and National Disaster Management Authority.
The new advisory include
• Three new categories have been included to whom HCQ will be prescribed as prophylactic treatment, they are as follows– Asymptomatic Health care workers working in non-Covid hospitals, Asymptomatic front line workers that include workers employed in containment zones, Paramilitary and police personnel
• The In-vitro testing of HCQ has showed reduction of infectivity of Covid-19
• The drug is not prescribed for children below 15 years of age
• The use of HCQ on high risk population has also been revised
• The drug has to be provided only through prescription of doctors.